Steatosis and inherited host factors influence liver damage progression in chronic hepatitis
C (CHC). The transmembrane 6 superfamily member 2 (TM6SF2) gene E167K variant …

Common diseases (including obesity, type 2 diabetes mellitus [T2DM], cardiovascular
disease and nonalcoholic fatty liver disease [NAFLD]) are complex traits resulting from …

In their study, Iavarone et al. 1 found a prolonged time to progression (TTP) in comparison
with the Sorafenib HCC Assessment Randomized Protocol study, and they speculated that it …

Nonalcoholic fatty liver disease (NAFLD) is caused by hepatic steatosis, which can progress
to nonalcoholic steatohepatitis, fibrosis/cirrhosis, and hepatocellular carcinoma in the …

Steatosis is a common histopathological feature of chronic hepatitis B (CHB) and has been
associated with severity of liver disease. Recently, the rs738409 I148M patatin‐like …

Remission induction therapy for acute lymphoblastic leukemia (ALL) includes medications
that may cause hepatotoxicity, including asparaginase. We used a genome‐wide …

Hepatocellular carcinoma (HCC) is highly associated with chronic liver disease. The
rs738409 genetic variant in the patatin-like phospholipase domain-containing 3 (PNPLA3 …

Background & Aims A common non‐synonymous polymorphism, E167K, in transmembrane
six superfamily member 2 (TM 6 SF 2) gene has been recently associated with an increased …

Introduction: Chronic hepatitis C (HCV) infection is considered a metabolic disease. It is
associated with a specific metabolic syndrome, HCV-associated dysmetabolic syndrome …

I read with interest the article regarding the role of imaging techniques in the treatment of
hepatocellular carcinoma (HCC) by Bruix et al. published in HEPATOLOGY. 1 In this special …